MEDS logo

DATAMEDS AI INC

MEDSNASDAQ
πŸ† #4918 by market capUS Equity
β€”β€”
Quote unavailable
πŸ””
Track MEDS
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$6M
Small Cap
πŸ“ˆRevenue Growth (YoY)
28.7%
High Growth
πŸ“ŠGross Margin
-132.7%
Thin
πŸ’΅FCF Margin
-205.2%
Thin
βš–οΈP/S Ratio
0.8x
Cheap
Otter Score
β€”
Insufficient data
No chart data available for MEDS.

Trading Snapshot

Day Range
β€”
52-Week Range
$0.49 – $33.15
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
4.5M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$23M
Last Q Revenue
β€”
P/E Ratio
-0.1
P/S Ratio
0.8x
EPS (TTM)
$-13.49
Dividend Yield
0.00%
Dilution (1yr)
+36.7%
MEDS logo

DATAMEDS AI INC

MEDS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$23Mβ–² +28.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-41.3%β–Ό βˆ’523.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$81Mβ–² +1221.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$12Mβ–² +632.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.4Mβ–² +36.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$25Mβ–Ό βˆ’$645K YoY
StockOtter Β· stockotter.space

About DATAMEDS AI INC

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRxβ„’ and blockchain-enabled smart contacts platform PharmacyChainβ„’ to optimize the prescription medicines reimbursement and dispensing journey.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.